Back to mobile site

Form SCHEDULE 13G Viking Therapeutics, Filed by: BlackRock, Inc.

February 4, 2025 3:46 PM EST

ATTACHMENTS / EXHIBITS

primary_doc.xml

EXHIBIT 24: POWER OF ATTORNEY

EXHIBIT 99: ITEM 7



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

SEC Filings

Related Entities

13G, S3